186 related articles for article (PubMed ID: 7496349)
1. Immunological definition of acute minimally differentiated myeloid leukemia (MO) and acute undifferentiated leukemia (AUL).
Bernier M; Massy M; Deleeuw N; Bron D; Debusscher L; Stryckmans P
Leuk Lymphoma; 1995; 18 Suppl 1():13-7. PubMed ID: 7496349
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts.
van't Veer MB
Ann Hematol; 1992 Apr; 64(4):161-5. PubMed ID: 1581403
[TBL] [Abstract][Full Text] [Related]
4. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
Naghashpour M; Lancet J; Moscinski L; Zhang L
Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
[TBL] [Abstract][Full Text] [Related]
5. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
7. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
8. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
[TBL] [Abstract][Full Text] [Related]
9. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
[TBL] [Abstract][Full Text] [Related]
10. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
11. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
12. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL).
Bene MC; Bernier M; Casasnovas RO; Castoldi G; Knapp W; Lanza F; Ludwig WD; Matutes E; Orfao A; Sperling C; van't Veer MB
Blood; 1998 Jul; 92(2):596-9. PubMed ID: 9657760
[TBL] [Abstract][Full Text] [Related]
13. [Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry].
Shen HQ; Tang YM; Yang SL; Qian BQ; Song H; Shi SW; Xu WQ
Zhonghua Er Ke Za Zhi; 2003 May; 41(5):334-7. PubMed ID: 14751050
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
15. [Lineage assignment in acute leukemia: confrontation between cytology and immunophenotyping].
Ben Salah N; El Borgi W; Chelbi A; Ben Lakhal F; Gouider E; Aounallah Skhiri H; Hafsia R
Pathol Biol (Paris); 2014 Dec; 62(6):345-7. PubMed ID: 25194892
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
17. Lineage commitment in biphenotypic acute leukemia.
Buccheri V; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
[TBL] [Abstract][Full Text] [Related]
18. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
[TBL] [Abstract][Full Text] [Related]
19. [Immunophenotyping analysis of acute undifferentiated leukemia].
Ezaki K; Shinkai K; Hirano M
Nihon Rinsho; 1992 Jun; 50(6):1249-54. PubMed ID: 1518141
[TBL] [Abstract][Full Text] [Related]
20. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
